首页> 外文期刊>Experimental Neurology >Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice
【24h】

Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice

机译:NRF2-活化剂碳酸降低小鼠创伤性脑损伤后的线粒体功能障碍,氧化损伤和神经元细胞骨架降解

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The importance of free radical-induced oxidative damage after traumatic brain injury (TBI) has been well documented. Despite multiple clinical trials with radical-scavenging antioxidants that are neuroprotective in TBI models, none is approved for acute TBI patients. As an alternative antioxidant target, Nrf2 is a transcription factor that activates expression of antioxidant and cytoprotective genes by binding to antioxidant response elements (AREs) within DNA. Previous research has shown that neuronal mitochondria are susceptible to oxidative damage post-TBI, and thus the current study investigates whether Nrf2-ARE activation protects mitochondrial function when activated post-TBI. It was hypothesized that administration of carnosic acid (CA) would reduce oxidative damage biomarlcers in the brain tissue and also preserve cortical mitochondrial respiratory function post-TBI. A mouse controlled cortical impact (CCI) model was employed with a 1.0 mm cortical deformation injury. Administration of CA at 15 min post-TBI reduced cortical lipid peroxidation, protein nitration, and cytoskeletal breakdown markers in a dose-dependent manner at 48 h post-injury. Moreover, CA preserved mitochondrial respiratory function compared to vehicle animals. This was accompanied by decreased oxidative damage to mitochondrial proteins, suggesting the mechanistic connection of the two effects. Lastly, delaying the initial administration of CA up to 8 h post-TBI was still capable of reducing cytoskeletal breakdown, thereby demonstrating a clinically relevant therapeutic window for this approach. This study demonstrates that pharmacological Nrf2-ARE induction is capable of neuroprotective efficacy when administered after TBI. (C) 2014 Elsevier Inc All rights reserved.
机译:创伤性脑损伤(TBI)后自由基诱导的氧化损伤的重要性已充分记录。尽管在TBI模型中具有神经保护的自由基清除抗氧化剂具有多种临床试验,但无需批准急性TBI患者。作为替代的抗氧化靶,NRF2是通过与DNA内的抗氧化剂反应元素(ARES)结合来激活抗氧化剂和细胞选择基因的表达的转录因子。以前的研究表明,神经元线粒体易患后TBI后氧化损伤,因此目前的研究研究了NRF2-活化是否在激活后TBI时保护线粒体功能。假设羰基酸(CA)的给药将减少脑组织中的氧化损伤生物碳粉,并保留TBI后皮质线粒体呼吸功能。使用1.0mm皮质变形损伤使用小鼠控制的皮质撞击(CCI)模型。在15分钟后,在15分钟后,在损伤后48小时内以剂量依赖性方式减少皮质脂质过氧化,蛋白质硝化和细胞骨骼衰弱标记物。此外,与载体动物相比,CA保存了线粒体呼吸功能。这伴随着线粒体蛋白的氧化损伤减少,表明两种效果的机械连接。最后,延迟高达8小时的Ca初始施用仍然能够降低细胞骨骼分解,从而证明这种方法的临床相关的治疗窗。该研究表明,在TBI施用时,药理学NRF2-诱导能够进行神经保护功效。 (c)2014年elsevier inc保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号